Live birth rates in various subgroups of poor ovarian responders fulfilling the Bologna criteria.
Sign Up to like & getrecommendations! Published in 2017 at "Reproductive biomedicine online"
DOI: 10.1016/j.rbmo.2017.03.009
Abstract: The European Society of Human Reproduction and Embryology published Bologna criteria to generate a definition of poor ovarian responders (PORs). However, there are few data on whether PORs are homogenous for ovarian response or live… read more here.
Keywords: birth rates; ovarian responders; group; bologna criteria ... See more keywords
Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF/ICSI cycles.
Sign Up to like & getrecommendations! Published in 2017 at "Reproductive biomedicine online"
DOI: 10.1016/j.rbmo.2017.09.002
Abstract: Previous studies show that a dual trigger ovulation regimen significantly improves number and maturity of retrieved oocytes for normal ovarian responders or patients with history of low oocyte yield. The current retrospective cohort study investigated… read more here.
Keywords: final oocyte; ovarian responders; dual trigger; rate ... See more keywords
Effect of the supplementation of recombinant Luteinizing Hormone on Cumulative Live Birth rate compared to Follitropin alfa alone on Poor Ovarian Responders. A real-world large study
Sign Up to like & getrecommendations! Published in 2020 at "Reproductive Biomedicine Online"
DOI: 10.1016/j.rbmo.2020.08.035
Abstract: Abstract Research question The benefit of Luteinizing Hormone supplementation (LHS) to FSH alone during Controlled Ovarian Stimulation (COS) remains controversial. Meta-analyses provided some evidence that the LHS benefit is limited to Poor Ovarian Responders (POR).… read more here.
Keywords: supplementation; ovarian responders; luteinizing hormone; study ... See more keywords
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000006443
Abstract: Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes of IVF have been conflicting. The… read more here.
Keywords: ovarian responders; addition; growth hormone; rate ... See more keywords